Blood Biomarkers for Alzheimer’s Dementia Diagnosis

Alzheimer’s disease (AD) represents a major public health concern and has been identified as a research priority. Clinical research evidence supports that the core cerebrospinal fluid (CSF) biomarkers for AD, including amyloid-β (Aβ42), total tau (T-tau), and phosphorylated tau (P-tau), reflect key...

Full description

Bibliographic Details
Main Author: Chang-Eun Park
Format: Article
Language:English
Published: The Korean Society for Clinical Laboratory Science 2022-12-01
Series:Korean Journal of Clinical Laboratory Science
Subjects:
Online Access:http://www.kjcls.org/journal/view.html?doi=10.15324/kjcls.2022.54.4.249